A Knee, a Forged Prescription and Six Years: The Ruti Aga Case That Was Never About a 'Steroid'

A knee. A prescription. And six years. Everything else — the medal, the prize money, the name of the race — stands at the edge of this story, like a spectator at the 40th kilometre of a marathon, watching the race but not deciding it. I first understood this case the day I remembered that empty-seated evening in Patiala — the 2026 Federation Cup, where the starter's pistol bounced off empty stands and I wrote in my notebook that absence, too, has a sound. Ruti Aga's case belongs to that sound. It is a story of what did not happen on the field but shakes the field's foundations. And the first thing I must correct is the word every headline got wrong.

What Every Outlet Printed, and What Actually Happened

For several days the headline was the same: Ethiopian marathoner Ruti Aga banned for six years on the basis of a forged prescription. According to the Athletics Integrity Unit (AIU) statement, a sample taken after she won a half marathon in China in March tested positive for a prohibited substance. The substance was methylprednisolone. And this is where two stories begin. The first, the one printed in newspapers, called it a "prohibited steroid" and said WADA classed it as performance-enhancing. The second, the one recorded in the pharmacology textbook, nobody read.

Methylprednisolone is not an anabolic steroid. It is a glucocorticoid — WADA Prohibited List class S9, not class S1. And this is not merely a difference of name. It is the difference at the very hinge of the entire case. I repeat it because in the speed at which this news spread, the nuance got buried. After 31 years in the world of track and field, I have learned one thing: when a case is sold as "steroid," the reporting stops exactly where understanding should have begun.

Who Ruti Aga Was — A Face Before a Number

I remember the race before the name, and the morning before the race. I first noticed Ruti Aga when she finished second at the 2026 Berlin Marathon — around 2:18:34, a time in that layer of elite women's marathoning the world calls "good" and forgets. The next year in Tokyo she won in around 2:20:40 — a World Marathon Major title. She also finished second at World Marathon Majors three times. This record, by any measure, belongs to a genuinely elite marathoner, no illusion.

(An honesty here is necessary: the AIU statement does not mention these times. The 2:18:34 and 2:20:40 are from my own records and remain to be independently verified. What is certain in the statement is that she won the 2026 Tokyo Marathon and finished second at Majors three times.)

But what separates Aga from the rest is not her time — it is her ecosystem. There is no competition to the depth of Ethiopian women's marathon. A country where even sub-2:16 runners are not automatically selected for the national team. Where the removal of a 2:18 runner is nearly invisible at national level. This is the cruelest truth of this story: Aga's ban does not move her country's marathon strength by a single millimetre. She is one bucket of water from a deep well.

Asian Evenings, African Races, and the Grey Zone Where Money and Testing Collide

Without understanding the economy of a marathoner, this case will not be understood. The Majors happen two or three times a year; in the other months these runners survive on Label races — and among them, the Asian circuit, especially China, is a large and wealthy source. Appearance fees, prize money, slower but safer races. For a runner of the 2:18–2:20 class this is exactly the model Aga adopted after 2026: selective Majors, and Asian Label races in between. (This is my observation, not part of the statement.)

The real collision hides here. This very Chinese Label-race circuit, which for East African runners is a comfortable income tier, is today also the AIU's biggest testing ground. The appearance-fee economy and the testing economy are now meeting face to face in the same races. The race that was once for money is now hunting like a trap. The fact that a sample was taken at that March Chinese half marathon means there was an elite women's field and a testing window — a road race's testing window opens at 23:59 the day before the race. Remember this technical fact; it becomes decisive.

The Real Issue: Not "Steroid," but "Route and Timing"

Now we come to the place where this whole case is decided, and from which every headline fled.

Glucocorticoids — like methylprednisolone — are under the current List prohibited in-competition only, and even then by injection, oral, or rectal route. Out-of-competition, a therapeutic injection into the knee is entirely legal. It is the daily treatment of hundreds of distance runners. I have seen knees wrapped in tape at camps in Patiala and Bhubaneswar, seen 4 a.m. physio sessions. Distance runners' knees age early — synovitis, chronic swelling, recurring pain. Methylprednisolone is the cheapest, easiest and most available weapon for that pain.

This means the whole case rested on when and how the injection was given — not on "steroid use." A legitimate, documented, time-appropriate therapeutic treatment could have saved this athlete. The path was clear: either obtain a Therapeutic Use Exemption (TUE), or observe WADA's route-specific washout period so nothing remained in the sample at competition time. Neither happened. And this is where the second half of the story begins — and this half became the killer of her career.

The Forged Prescription: Not One, but Three Verification Failures

According to the AIU statement, Aga cited a knee injury. The prescription came from a clinic that did not exist. The "doctor" who wrote it was a family member with no medical registration. And that person claimed to have used an "old prescription pad from a former workplace" — which the clinic explicitly disowned.

Three separate points of verification failed. Three. This is no small filing error. It is the testimony of an athlete running on an informal and unregistered medical network, without a credentialed team physician. And when the investigation came, that network had nothing with which to tell the truth — except a prescription that turned out to be false.

Here I want to pause and say something, because this is where a journalist can slip. Two decades of access have taught me that quoting officials is easy and reading the athlete's side of the ledger is hard. So let me say plainly: this is the athlete's offence, no doubt. But it is also true that this offence was born from the vacuum where a credentialed team doctor should have been and was not. I am not erasing the fault. I am only showing where it came from.

2 + 4 = 6: An Arithmetic That Reveals the Panel's Thinking

Now the arithmetic I write first in my notebook, because numbers do not lie — statements can.

Two years for the presence violation. Four years for tampering. Six years total, counted from 10 September — the same date she was under provisional suspension.

This arithmetic tells a story by itself. A two-year ban is standard for a Specified Substance case where intent is not proven. Four years is the Code's standard sanction for tampering. The sum tells us the panel rejected the "no significant fault" mitigation that could otherwise have reduced the presence sanction. And it creates a paradox: forged documentation is itself circumstantial evidence of concealment intent, yet it did not escalate the presence sanction — it merely added a separate, heavier charge. (This is my structural analysis; these sanction figures exist in the statement, but their interpretation is mine.)

And here is something often misunderstood: backdating the ban to 10 September is no concession. Provisional suspension time counts against the sentence — the athlete gains nothing real. It is procedural justice, not mercy.

But the real question is this: six years for a substance with no proven endurance benefit? This figure will be cited from both sides — some will call it proof of AIU rigour, some of inconsistent enforcement against African road runners. I place both sides, because there is truth in both.

The Counter-Intuitive Side: The Blind Spot That Misreads This Whole Case

Now the turn, where I point to the blind spot of collective memory that is repeated every time and is wrong every time.

The media presented this case as another chapter of "doping." Steroid, offence, punishment — three words, and the story is over. But in this frame, what disappears is exactly what makes it different: methylprednisolone is a substance that gives a 100m sprinter no benefit, but for an injured marathoner it is sometimes the difference between running and not running. In endurance sports, glucocorticoid misuse is mainly to mask pain — so an injured runner can take one more race, earn one more appearance fee, avoid giving her knee a month's rest. This is not the substance of "getting faster"; it is the substance of "staying broken."

The real systemic truth hides here. An elite runner must compete — because her income depends on her running, and if she does not run, someone else takes her place. In this economy, masking pain becomes a rational decision. And when medicine is needed to mask pain, the cheapest and easiest thing is grabbed first. This is no excuse — it is a structure. And this structure looks the same in those Ethiopian-Kenyan training clusters where one informal medical network serves dozens of runners.

This is why the case is not isolated; it belongs to the family in which, on top of an initial substance violation, a fabricated or altered explanation is added. And here the real frontier of enforcement is shifting: the question is now moving from "was a substance found" to "is the document real." The four years for tampering is the sentinel of that new frontier.

One more blind spot: assuming a six-year ban is "a big punishment." For a 32-year-old runner, it need not merely be long — it may even be light. If a 38-year-old with a doping record returns in Ethiopian women's marathon, her chance of selection is near zero. This is not six years; it is really the end of a career — merely written on paper as six years. The sentence is on paper; the effect is for life.

The Missing Number

And here is the thing no one looks at: the time of that March half marathon is recorded nowhere. No split, no field strength, no mark that won it. Not even the name of the race. The AIU statement says only that she won it and the sample was positive.

This absence is itself a statement. In this case the result is secondary; the disqualification is the story. In road running the testing window opens a day before the race — so an injection given days earlier can still be caught. A result never declared, prize money never mentioned. I wrote in my notebook: some names are erased from the record, and the record does not flinch. This is that moment.

One Thing That Survives: 2026

Now the part that is perhaps least discussed, but most important to me. The violation is tied to a much later March race. No finding of earlier use emerged. So, in principle, results before that date — including the 2026 Tokyo Marathon win and three Major runner-up finishes — are not automatically annulled. The statement does not say what the scope of disqualification is, and this silence matters.

I am not saying those results are sacred. I am saying that a marathon time is the product of that morning's wind, that day's effort and that day's knee — and erasing or preserving it with a later forged prescription, both carry their own politics. Memory's choice is never neutral. We made Milkha immortal and left Usha on the margins; we nearly forgot a World Championships bronze won with one kidney. This same memory politics will decide in what colour Ruti Aga's name is remembered — in the golden Tokyo entry, or in that anonymous March half marathon.

What I Learned on the Field, and How It Applies Here

I have been measuring this sport for 31 years, and I still keep a stopwatch in my pocket — not for the result, but to measure how long a stadium echoes after a goal. Writing about an Ethiopian runner, what can I add from Chennai? This: the sport's real scarcity is not talent, it is oversight — and the lack of oversight devours first those athletes who have no credentialed doctor, no proper manager, and no TUE file. In India I have seen the same — when runners on railway and Services job quotas get injured, their treatment is often just as informal, and their documentation just as informal. The risk differs there, the structure is one.

We have seen the 2026 Commonwealth boom and the 2026 doping earthquake. One thing has not changed: an athlete with strong institutional backing is protected by the system in injury; one without it suffers. Aga had a title, three Major runner-up finishes — but in her moment of crisis she had no doctor. Just a relative and an old pad.

Looking Ahead: What Is Not Yet on Paper

This case looks like a closed file, but I think it is a beginning. Three questions are open before me, and time will answer them.

First, the appeal. After the reasoned decision, Aga usually has a CAS appeal window of about 21 days. The forged-document finding is document-based and hard to overturn — but not impossible, if someone can show a procedural gap in the tampering finding. Chance of success low, but not zero.

Second, the scope. The March race result and its prize money will almost certainly be annulled, along with ranking points accumulated after that date. This is standard practice, even if the statement does not say so.

Third — and most important — the pipeline. When one informal medical network serves dozens of runners in the same training cluster, one case being caught does not say the rest are clean; it says the rest have simply not been investigated yet. Three or four more names may land on my desk. And if they do, the same question will return each time: for whom is six years easy? The one with a lawyer, or the one with only a relative's old pad?

The sport's real star is not time, it is attention — who is watched, and for how long. We are seeing Ruti Aga only now, when her prescription turned out false. On the day she won in sub-2:20 in Tokyo, how many opened that result? Empty stands have a sound of their own, and I have spent a year learning to hear it. This sound belongs not only to that Chinese half marathon whose name we do not even know, but to every race we do not see until the blow of a headline. And if anything survives this story, it will not be the sentence — it will be the question that an injured knee needed a qualified doctor, and one was never there. In a race where no one treats your injury, there is no point in being the fastest.